| J9312 | Injection, rituximab, 10 mg | 7,250 | $60 | $456.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 14,280 | $30 | $371.2K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,150 | $10 | $91.5K |
| J0897 | Injection, denosumab, 1 mg | 3,360 | $20 | $60.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 420 | $100 | $41.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $90 | $20.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 310 | $60 | $17.4K |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 30 | $530 | $17K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 450 | $20 | $9.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $110 | $5.4K |